Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Chronic ***
>
Treatment
>
Co: USA. A. Ponatinib
>
Mechanism: BCR-ABL inhibitor
Mechanism: BCR-ABL inhibitor's products
This section has no products